About Natco Pharma Ltd
Natco Pharma is engaged in the business of pharmaceuticals and agricultural chemicals which comprises research and development, manufacturing and selling of bulk drugs, finished dosage formulations.
Founded
1981
CEO
V C Nannapaneni
Employees
4,955
HQ
Hyderabad, Telangana
Finished Products
1Sale of Products
₹7,243.20Cr2Sale of Services
₹380.30Cr3Export Incentives
₹18.80Cr4Other Operating Revenues
₹7.10Cr5Government incentive schemes
₹6.40Cr6Scrap Sales
₹5.60Cr7Job Work Charges Received
₹2.00CrRaw Materials
1Raw Material Consumed
₹961.70Cr2Packing Material
₹97.00Cr3Purchases
₹80.30CrAbout Natco Pharma Ltd
Natco Pharma is engaged in the business of pharmaceuticals and agricultural chemicals which comprises research and development, manufacturing and selling of bulk drugs, finished dosage formulations.
Founded:1981
CEO:V C Nannapaneni
Employees:4,955
HQ:Hyderabad, Telangana
Finished Products
1Sale of Products
₹7,243.20Cr2Sale of Services
₹380.30Cr3Export Incentives
₹18.80Cr4Other Operating Revenues
₹7.10Cr5Government incentive schemes
₹6.40Cr6Scrap Sales
₹5.60Cr7Job Work Charges Received
₹2.00CrRaw Materials
1Raw Material Consumed
₹961.70Cr2Packing Material
₹97.00Cr3Purchases
₹80.30CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹1,227
52W Low
₹789
Volume472.80K
Avg VolumeN/A
Beta1.06
Dividend Yield0.59%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
13.19x
Valuation
P/B Ratio
1.64x
Valuation
EPS
₹63.91
Valuation
Dividend Yield
0.59%
Valuation
ROE
15.38%
Profitability
ROCE
15.37%
Profitability
Revenue by Segment
Contribution & growth by business line
Pharmaceuticals
+37.4%98.5%
₹2,666.2 Cr
Agro chemicals
+734.7%1.5%
₹40.9 Cr
Geographical Revenue Split
Domestic vs international exposure
Domestic
12.4%
International
87.6%
USA71.4%
Rest of the world16.2%
India12.4%
Strategic Relations
Collaborations, joint ventures & subsidiaries
I
ITOCHU
Japan
0.00% stakeF
Flour Daniels
United States
0.00% stakeH
HAM
Netherland
0.00% stakeForensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.08x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
17.8%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.